Last updated: April 29, 2024
Sponsor: Queen Mary Hospital, Hong Kong
Overall Status: Active - Recruiting
Phase
N/A
Condition
Genitourinary Prolapse
Enuresis
Urinary Incontinence
Treatment
TURP
Prostatic Urethral Lift
Clinical Study ID
NCT06037356
QMH PULTUR Study
Ages > 40 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Male patients
- age >40 years old
- urinary retention who failed trial without catheter
Exclusion
Exclusion Criteria:
- Inability to provide consent OR no guardians or relatives to help provide consent onpatient's behalf
- Active urinary tract infection
- Previous surgical treatment for benign prostatic hyperplasia (i.e., TURP, prostaticurethral lift, etc.)
- Bladder stones
- Urethral strictures or bladder neck contractures
- Prostate size >100mL
- Solely obstructing median lobe
- Urinary retention not due to obstruction (i.e., Bladder outflow obstruction index <20on urodynamic studies)
- Poor detrusor contractility (maximum detrusor pressure <20cmH2O during voiding phase)
- Anticoagulant or antiplatelet agents that cannot be stopped
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: TURP
Phase:
Study Start date:
June 01, 2024
Estimated Completion Date:
May 30, 2032
Study Description
Connect with a study center
Queen Mary Hospital
Hong Kong,
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.